Neuroinfuse TBI IV Therapy

Novel treatment strategy to treat acute and chronic stages of traumatic brain injury and other neurodegenerative disorders. Neuroinfuse provides platform for direct CNS delivery of therapeutic agents including monoclonal antibodies, small molecules, stem cells and other vector-based gene therapies. This novel therapeutic approach allows for single and/or serial infusion of the therapeutics without need for hospitalization.